Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes
H Hirose, T Kawai, Y Yamamoto… - Metabolism …, 2002 - metabolismjournal.com
The aim of this study was to evaluate the effects of pioglitazone on clinical and metabolic
parameters, body fat distribution, and serum adiponectin, a recently discovered
antiatherosclerotic hormone, in Japanese patients with type 2 diabetes. Ten male patients
aged 40 to 66 (57.7 [plusmn] 7.4) years, who were being treated with dietary therapy alone
(n= 7) or with a stable dose of sulfonylurea (n= 3), were studied at baseline and after 3
months of pioglitazone treatment (30 mg/d). Body mass index (BMI), blood pressure, fasting …
parameters, body fat distribution, and serum adiponectin, a recently discovered
antiatherosclerotic hormone, in Japanese patients with type 2 diabetes. Ten male patients
aged 40 to 66 (57.7 [plusmn] 7.4) years, who were being treated with dietary therapy alone
(n= 7) or with a stable dose of sulfonylurea (n= 3), were studied at baseline and after 3
months of pioglitazone treatment (30 mg/d). Body mass index (BMI), blood pressure, fasting …
